Widespread statin use under NICE 2014 guidelines

Widespread statin use under NICE 2014 guidelines PharmacoEconomics & Outcomes News 784, p31 - 12 Aug 2017 Widespread statin use under NICE 2014 guidelines Statin treatment would be required by 11.8 million adults in England under the UK NICE 2014 guidelines for cardiovascular risk and lipid modification, according to an article in the British Journal of General Practice. The 2014 update of the NICE guidelines reduced the treatment threshold for statin therapy from the previous 10-year cardiovascular risk level of 20% or over, to 10% or over, for all adults without a previous history of cardiovascular disease. In addition, the guideline update endorsed the QRISK2 algorithm to estimate cardiovascular risk. A cross-sectional study was conducted to investigate risk factor levels required to exceed the risk threshold for statin therapy, and to estimate statin usage, based on the 2014 guidelines. Using data from the Health Survey for England, the 10-year cardiovascular risk for adults aged 30–84 years was estimated by inputting varying combinations of risk factors into the QRISK2 algorithm. Even with optimal risk factor levels, the authors found that the 10-year cardiovascular risk threshold would be exceeded by males between the ages of 60 and 70 years, and by females between the ages of 65 and 75 years, regardless of ethnicity. Under the 2014 NICE guidelines, 11.8 million adults aged 30–84 years in England would require statin therapy, which would represent 37% of this demographic. Almost two-thirds of the 9.8 million people without cardiovascular disease who would require statins under the guidelines were eligible for, but not receiving, statin treatment. Discussing the implications of the findings for practice, the authors highlighted that "even if providing statin therapy to a large part of the population is deemed to be cost-effective, it will still require resources to screen, treat, and monitor the patients who are put on treatment". Ueda P, et al. Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis. British Journal of General Practice : 31 Jul 2017. Available from: URL: https://doi.org/10.3399/bjgp17X692141 803263658 1173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 12 Aug 2017 No. 784 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

Widespread statin use under NICE 2014 guidelines

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/widespread-statin-use-under-nice-2014-guidelines-55trng7LVf
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
D.O.I.
10.1007/s40274-017-4242-y
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics & Outcomes News 784, p31 - 12 Aug 2017 Widespread statin use under NICE 2014 guidelines Statin treatment would be required by 11.8 million adults in England under the UK NICE 2014 guidelines for cardiovascular risk and lipid modification, according to an article in the British Journal of General Practice. The 2014 update of the NICE guidelines reduced the treatment threshold for statin therapy from the previous 10-year cardiovascular risk level of 20% or over, to 10% or over, for all adults without a previous history of cardiovascular disease. In addition, the guideline update endorsed the QRISK2 algorithm to estimate cardiovascular risk. A cross-sectional study was conducted to investigate risk factor levels required to exceed the risk threshold for statin therapy, and to estimate statin usage, based on the 2014 guidelines. Using data from the Health Survey for England, the 10-year cardiovascular risk for adults aged 30–84 years was estimated by inputting varying combinations of risk factors into the QRISK2 algorithm. Even with optimal risk factor levels, the authors found that the 10-year cardiovascular risk threshold would be exceeded by males between the ages of 60 and 70 years, and by females between the ages of 65 and 75 years, regardless of ethnicity. Under the 2014 NICE guidelines, 11.8 million adults aged 30–84 years in England would require statin therapy, which would represent 37% of this demographic. Almost two-thirds of the 9.8 million people without cardiovascular disease who would require statins under the guidelines were eligible for, but not receiving, statin treatment. Discussing the implications of the findings for practice, the authors highlighted that "even if providing statin therapy to a large part of the population is deemed to be cost-effective, it will still require resources to screen, treat, and monitor the patients who are put on treatment". Ueda P, et al. Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis. British Journal of General Practice : 31 Jul 2017. Available from: URL: https://doi.org/10.3399/bjgp17X692141 803263658 1173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 12 Aug 2017 No. 784

Journal

PharmacoEconomics & Outcomes NewsSpringer Journals

Published: Aug 12, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off